BTC $ 38,308.28 -0.138315%
ETH $ 2,751.54 0.461085%
MARKET CAP $ 0%
ICOs 8,615

Vivo Capital

ICO Ended
16,500 Views
Future of Healthcare Innovation. At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees. Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

6.8
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

5
SOCIAL ACTIVITY

(weight: 35%)

7
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 01 Oct 2018 - 15 Oct 2018
ICO Time: 16 Oct 2018 - 31 Dec 2018
Country: USA
Token info
Ticker: VCT
Platform: Ethereum
Token Type: ERC20
Financial
ICO Price: 0.0042 USD
Accepting: ETH
Soft cap: 120,000,000 USD
Hard cap: 280,000,000 USD
Q1 2018

• Generating the idea.


• Evaluating the market and development potential.


• Market Research.

Q2 2018

• Launching the development.


• Expanding the team.


• Developing the company's legal structure.

Q3 2018

• Preparing for the ICO.


• Whitepaper


• Landing page


• Performing Private Sale


• Bounty & AirDrop

Q4 2018

• Performing the Pre-sale.


• Performing ICO Main sale.


• Bounty & AirDrop Distribution.

Q1 2019

• Exchange Listing Process starts.


• Mobile application testing


• Establishing Representative Office

Q2 2019

• Launch the Platform in Full mode


• Mobile application release

Q3 2019

• Marketing


• Licensing and entering the Asian market.

Q4 2019

• Obtaining the payment licenses.


• Completion of developing the platform core.

Lawrence Wang
Managing Director
Participates in several projects
Michael Chang
Managing Director
Participates in several projects
Jack Bech Nielsen
Managing Director
Participates in several projects
Gaurav Aggarwal
Managing Director
Participates in several projects
Frank Kung
Managing Partner
Participates in several projects
Albert Cha
Managing Partner
Participates in several projects
Shan Fu
Managing Partner
Participates in several projects
Chen Yu
Managing Partner
Participates in several projects
Derek Yang
Finance Director
Participates in several projects
Peiyi Zhao
Head of Legal
Participates in several projects
Albert Chang
Managing Partner
Participates in several projects
Edgar G. Engleman
Managing Partner
Participates in several projects
Mahendra G. Shah
Managing Director
Participates in a number of projects
Hwachie Lee
Managing Director
Participates in a number of projects
Jo Shen
Venture Partner
Participates in a number of projects
Yuh-geng Tsay
Venture Partner
Participates in a number of projects
Tracy Wu
General Director
Participates in a number of projects
Joseph Siletto
Managing Director
Participates in a number of projects
Daisy Xu
General Director
Participates in several projects
Nathan Dau
Associate
Participates in several projects
Eric Trac
Associate
Participates in several projects
Tiantian Zhu
Analyst
Participates in several projects
Ethan Zhao
Associate
Participates in several projects
Tierney Y. Li
Analyst
Participates in several projects
Andrew D. Goldberg
Principal
Participates in several projects
Vinayak Nikam
Associate
Participates in several projects
Adrianne Chang
Consultant
Participates in several projects
Dan Dan Dong
Principal
Participates in several projects
Qi Zhu
Principal
Participates in several projects
Nina Feng
Principal
Participates in several projects
Kevin Dai
Principal
Participates in several projects
David Liu
Principal
Participates in a number of projects
Daniel Qin
Associate
Participates in a number of projects
Lingfei Zhao
Analyst
Participates in a number of projects
Sue Shao
Associate
Participates in a number of projects
Yixuan Li
Analyst
Participates in a number of projects
Waika Cheng
Analyst
Participates in a number of projects
Aaron Royston
Senior Associate
Participates in several projects
Ronghuan Lin
Advisor
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
ASENIX TOKEN
A web3 platform that supports and invests in teams committed to developing swift innovative long-term solutions to ocean pollution. Earn rewards on every buy and sell transactions.
Active
Launchpad xyz
Join our crypto whales on Launchpad xyz and find the next 10x trade. Tired of waiting on presale promises or getting dumped on? Launchpad xyz will show you how we find multiple 10x return trades every month. Learn how to become a winner with us and together we will reveal the secrets of web3 crypto trading. Buy your NFT access card with $LPX tokens and join our VIP trading channels.
Upcoming
TradeLeaf
TradeLeaf seeks to become the leading digital trade financing platform operating on a global scale, shaping the future of trade finance market. TradeLeaf acts as a systems integrator, uniting numerous solutions and services under a single platform supported by a complex architecture and effective technical practices. Trade Leaf is a technology company driven by a team of traditional trade finance business leaders, blockchain visionaries, venture investors, and tech entrepreneurs cooperating to disrupt the conservative and bureaucratized trade finance industry. We create, integrate, and provide institutional-grade FinTech solutions and services for all trade finance industry participants. Our goal is to cover the trillion market gap supporting SMEs and MSMEs on emerging market.
Active
yPredict
yPredict.ai is an ecosystem of AI/ML experts, financial quants, traders, and investors. The range of products includes analytical tools & platforms designed to provide insights and analytics through state-of-art financial prediction methods and metrics built with alternate data to make wise trading and investment decisions. Financial markets including crypto tend to lose their predictability due to a significant volume of trades being executed through sophisticated algos which tend to evolve and improve themselves, this changes the dynamics of price structure formations constantly and thus making financial markets incredibly difficult to predict for humans including price action traders who specializes in understanding and predicting market moves through price structure formations. With these complexities in financial markets, traders and an investor are left with extreme noise and no statistical edge. As the majority of market participants rely solely on news and public opinion on social media and trading signals from dishonest signal providers. This is where yPredict.ai aims to bridge the gap and play a significant role, by providing access to data-driven insights, proven analytical metrics, and a prediction marketplace where financial data scientists can offer results/signals generated through their predictive models as a monthly subscription service. yPredict.ai platforms including the marketplace would provide them with a market to sell their model predictions as a service. Thus leveraging and harnessing their skills without the need of dealing with trading operations or having to find a market for their predictive models.
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.